Concepedia

Anna Szmigielska‐Kapłon

AS

25

Publications

591

Citations

17

H-Index

1999

Active since

Affiliations

Medical University of Lodz(Current)

Copernicus Memorial Hospital

Instytut Hematologii i Transfuzjologi

Medical University of Warsaw

Gdańsk Medical University

Anna Szmigielska‐Kapłon is an author at Medical University of Lodz specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1999–2023

25

Publications

25

MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.

Krzysztof Jamroziak, Ewa Balcerczak, Piotr Smolewski et al. · PubMed · 2007 · 54 citations

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma

Tadeusz Robak, Piotr Smolewski, Barbara Cebula‐Obrzut et al. · Cancer · 2006 · 50 citations

Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells

Piotr Smolewski, Anna Szmigielska‐Kapłon, Barbara Cebula‐Obrzut et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 43 citations

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

Marta Sobas, Jean‐Jacques Kiladjian, Yan Beauverd et al. · Blood Advances · 2022 · 41 citations · Full text

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience

Grzegorz Basak, Wanda Knopińska‐Posłuszny, Magdalena Matuszak et al. · Annals of Hematology · 2010 · 37 citations · Full text

Rows per page

1–5 of 25